MU vs PFE: Which Is the Better Buy?

Side-by-side comparison of Micron Technology, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-25.

Micron Technology, Inc. · Technology

$1,048.51

-45.0% upside to fair value

Grade C

PFE

Pfizer Inc. · Healthcare

$25.22

+2.8% upside to fair value

Grade B

QuantHub Verdict

PFE has more upside to fair value (+2.8%). PFE trades at a lower forward P/E (19.2x). These are model outputs — not personalized investment advice. See all research →

Valuation & Fundamentals

Metric	MU	PFE
Current Price	$1,048.51	$25.22
Fair Value Estimate	$576.68	$25.92
Upside to Fair Value	-45.0%	+2.8%
Market Cap	$1,182.4B	$143.7B
Forward P/E	23.4x	19.2x
EV / EBITDA	25.9x	12.3x
Price / Sales	13.1x	2.3x
Price / FCF	25.8x	15.2x
Revenue Growth YoY	+345.7%	+5.4%
Gross Margin	72.6%	69.3%
Operating Margin	65.7%	23.4%
Return on Equity	70.5%	8.4%
Dividend Yield	0%	0%
FCF Yield	3.87%	6.6%
Analyst Consensus	Strong Buy	Hold

Investment Thesis

MU — Micron Technology, Inc.

Micron Technology is a leading semiconductor company specializing in DRAM and NAND memory products, with a strong focus on high-value memory for cloud and AI applications. The company benefits from scale, advanced process technology, and U.S.-based manufacturing, but its competitive moat is narrow and cyclical compared to peers like Samsung and SK Hynix. Micron's recent financial performance is e…

PFE — Pfizer Inc.

Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…

Accumulation Zones

Metric	MU	PFE
Zone Low	$432.51	$19.44
Zone High	$490.18	$22.03
In Buy Zone?	No	No

← MU Research PFE Research → All Research